Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Cardiovascular Translational Research
Erschienen in: Journal of Cardiovascular Translational Research 4/2009

01.12.2009

Solutions for Disparities for Women with Heart Disease

verfasst von: Kathryn M. O’Callaghan

Erschienen in: Journal of Cardiovascular Translational Research | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Cardiovascular disease (CVD) mortality and morbidity is a major burden on the US and global population. Observed differences in prevalence, incidence, outcomes, and risk factors suggest a possible sex difference in etiology and pathophysiology of CVD. Disparate rates of referral and diagnosis may be attributable to differences in symptoms, presentation, and diagnostic accuracy. Many common procedural, pharmaceutical, and medical device therapies have been associated with worse outcomes in women compared to men. Awareness campaigns and efforts to improve female inclusion in clinical trials are contributing to improvements in CVD healthcare delivery for women, but much remains unknown about the biological basis for the differences described above, such as the role of estrogen, life-cycle changes (puberty, menstrual cycle, pregnancy, menopause), and possible chromosomal or genetic mechanisms. This is where translational research is uniquely poised to make immense contributions to resolving disparities in the quality of care and outcomes for women with CVD.
Literatur
1.
American Heart Association. (2008). Statistical fact sheet. Women and cardiovascular diseases. Dallas: American Heart Association.
2.
American Heart Association. (2008). Heart disease and stroke statistics—2008 update. Dallas: American Heart Association.
3.
4.
5.
Ambrose, J. A., & Barua, R. S. (2004). The pathophysiology of cigarette smoking and cardiovascular disease: an update. Journal of the American College of Cardiology, 43, 1731–1737.CrossRefPubMed
6.
Diverse Populations Collaboration. (2004). Smoking, body weight, and CHD mortality in diverse populations. Preventive Medicine, 38, 834–840.CrossRef
7.
Hokanson, J. E., & Austin, M. A. (1996). Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. Journal of Cardiovascular Risk, 3(2), 213–219.CrossRefPubMed
8.
Kanaya, A. M., Grady, D., & Barrett-Connor, E. (2002). Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Archives of Internal Medicine, 162, 1737–1745.CrossRefPubMed
9.
Shaw, L. J., Bairey Merz, C. N., Pepine, C. J., Reis, S. E., Bittner, V., Kelsey, S. F., et al. (2006). Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. Journal of the American College of Cardiology, 47(3 Suppl), S4–S20.CrossRefPubMed
10.
Mosca, L., Banka, C. L., Benjamin, E. J., Berra, K., Bushnell, C., Dolor, R. J., et al. (2007). Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Journal of the American College of Cardiology, 49(11), 1230–1250. Review.CrossRefPubMed
11.
Mosca, L., Linfante, A. H., Benjamin, E. J., Berra, K., Hayes, S. N., Walsh, B. W., et al. (2005). National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation, 111(4), 499–510.CrossRefPubMed
12.
Gibbons, R. J., Balady, G. J., Bricker, J. T., Chaitman, B. R., Fletcher, G. F., Froelicher, V. F., et al. (2002). ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation, 106(14), 1883–1892.CrossRefPubMed
13.
Mieres, J. H., Shaw, L. J., Hendel, R. C., Miller, D. D., Bonow, R. O., Berman, D. S., et al. (2003). American Society of Nuclear Cardiology consensus statement: Task Force on Women and Coronary Artery Disease–the role of myocardial perfusion imaging in the clinical evaluation of coronary artery disease in women [correction]. Journal of Nuclear Cardiology, 10(1), 95–101.CrossRefPubMed
14.
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998). Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation, 98(8), 731–733.PubMed
15.
Polk, D. M., & Naqvi, T. Z. (2005). Cardiovascular disease in women: sex differences in presentation, risk factors, and evaluation. Current Cardiology Reports, 7(3), 166–172.CrossRefPubMed
16.
Keyhani, S., Scobie, J. V., Hebert, P. L., & McLaughlin, M. A. (2008). Gender disparities in blood pressure control and cardiovascular care in a national sample of ambulatory care visits. Hypertension, 51(4), 1149–1155.CrossRefPubMed
17.
Centers for Medicare and Medicaid Services. (2005). Medicare Quality Improvement Organization Program. Baltimore: Centers for Medicare and Medicaid Services.
18.
Fremont, A. M., Correa-de-Araujo, R., & Hayes, S. N. (2007). Gender disparities in managed care: it's time for action. Womens Health Issues, 17(3), 116–119.CrossRefPubMed
19.
Blomkalns, A. L., Chen, A. Y., Hochman, J. S., Peterson, E. D., Trynosky, K., Diercks, D. B., et al. (2005). Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. Journal of the American College of Cardiology, 45(6), 832–837.CrossRefPubMed
20.
Anand, S. S., Xie, C. C., Mehta, S., Franzosi, M. G., Joyner, C., Chrolavicius, S., et al. (2005). Differences in the management and prognosis of women and men who suffer from acute coronary syndromes. Journal of the American College of Cardiology, 46(10), 1845–1851.CrossRefPubMed
21.
Brodie, B. R., Stone, G. W., Cox, D. A., Stuckey, T. D., Turco, M., Tcheng, J. E., et al. (2006). Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trial. American Heart Journal, 151(6), 1231–1238.CrossRefPubMed
22.
Vaccarino, V., Lin, Z. Q., Kasl, S. V., Mattera, J. A., Roumanis, S. A., Abramson, J. L., et al. (2003). Sex differences in health status after coronary artery bypass surgery. Circulation, 108(21), 2642–2647.CrossRefPubMed
23.
Vaccarino, V., Abramson, J. L., Veledar, E., & Weintraub, W. S. (2002). Sex differences in hospital mortality after coronary artery bypass surgery: evidence for a higher mortality in younger women. Circulation, 105(10), 1176–1181.CrossRefPubMed
24.
Edwards, F. H., Carey, J. S., Grover, F. L., Bero, J. W., & Hartz, R. S. (1998). Impact of gender on coronary bypass operative mortality. Annals of Thoracic Surgery, 66(1), 125–131.CrossRefPubMed
25.
Puskas, J. D., Kilgo, P. D., Kutner, M., Pusca, S. V., Lattouf, O., & Guyton, R. A. (2007). Off-pump techniques disproportionately benefit women and narrow the gender disparity in outcomes after coronary artery bypass surgery. Circulation, 116(11 Suppl), I192–I199.PubMed
26.
27.
Ebert, S. N., Liu, X. K., & Woosley, R. (1998). Female gender as a risk factor for drug-induced cardiac arrhythmias: evaluation of clinical and experimental evidence. Journal of Women's Health, 7, 547–557.CrossRefPubMed
28.
Kaczmarek, R. G., Liu, C. H., & Gross, T. P. (2003). Medical device surveillance: gender differences in pulmonary artery rupture after pulmonary artery catheterization. Journal of Women's Health (Larchmt), 12(9), 931–935.CrossRef
29.
Holmes, D. R., Jr., Kip, K. E., Kelsey, S. F., Detre, K. M., & Rosen, A. D. (1997). Cause of death analysis in the NHLBI PTCA Registry: results and considerations for evaluating long-term survival after coronary interventions. Journal of the American College of Cardiology, 30(4), 881–887.CrossRefPubMed
30.
Abbott, J. D., Vlachos, H. A., Selzer, F., Sharaf, B. L., Holper, E., Glaser, R., et al. (2007). Gender-based outcomes in percutaneous coronary intervention with drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry). American Journal of Cardiology, 99(5), 626–631. Epub 2007 Jan 9.CrossRefPubMed
31.
Lansky, A. J., Ng, V. G., Mutlu, H., Cristea, E., Guiran, J. B., Midei, M, et al. (2009). Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the spirit III randomized trial. Catheterization and Cardiovascular Interventions. in press.
32.
Lansky, A. J., Costa, R. A., Mooney, M., Midei, M. G., Lui, H. K., Strickland, W., et al. (2005). Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease. Journal of the American College of Cardiology, 45(8), 1180–1185.CrossRefPubMed
33.
Deng, M. C., Edwards, L. B., Hertz, M. I., Rowe, A. W., Keck, B. M., Kormos, R., et al. (2005). Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report–2005. Journal of Heart and Lung Transplantation, 24(9), 1182–1187.CrossRefPubMed
34.
35.
36.
Mosca, L., Mochari, H., Christian, A., Berra, K., Taubert, K., Mills, T., et al. (2006). Circulation, 113, 525–534.CrossRefPubMed
37.
Heart Failure Society of America. (2006). HFSA 2006 Comprehensive Heart Failure Practice Guideline. Journal of Cardiac Failure, 12(1), e1–e2.CrossRefPubMed
38.
Merkatz, R. B., Temple, R., Subel, S., Feiden, K., & Kessler, D. A. (1993). Women in clinical trials of new drugs. A change in Food and Drug Administration policy. The Working Group on Women in Clinical Trials. New England Journal of Medicine, 329(4), 292–296.CrossRefPubMed
39.
40.
Huang, S. M., Miller, M., Toigo, T., Chen, M., Sahajwalla, C., Lesko, L. J., et al. (2004). Drug metabolism/clinical pharmacology—Evaluation of drugs in women: Regulatory perspective. In M. Legato (Ed.) Principles of gender-specific medicine (pp 848–859). New York: Academic, section editor Schwartz J.CrossRef
41.
42.
DHHS/FDA. (2008). Sex differences in cardiovascular device trials; Public Workshop (Docket No. FDA-2008-N-0038). Federal Register, 73, 229.
43.
AMA Council on Ethical & Judicial Affairs Report B – I-90. (1991). Gender disparities in clinical decision-making. JAMA, 266, 559–562.CrossRef
44.
Bazett, H. C. (1918). An analysis of the time relationship of electrocardiograms. Heart, 7, 353–370.
45.
Rautaharju, P. M., Zhou, S. H., Wong, S., Calhoun, H. P., Berenson, G. S., Prineas, R., et al. (1992). Sex differences in the evolution of the electrocardiographic QT interval with age. Canadian Journal of Cardiology, 8(7), 690–695.PubMed
46.
Ray, J. G., Vermeulen, M. J., Schull, M. J., & Redelmeier, D. A. (2005). Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet, 366(9499), 1797–1803.CrossRefPubMed
47.
Shah, B. R., Retnakaran, R., & Booth, G. L. (2008). Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care, 31(8), 1668–1669. Epub 2008 May 16.CrossRefPubMed
48.
49.
Chen, Z., Yuhanna, I. S., Galcheva-Gargova, Z., Karas, R. H., Mendelsohn, M. E., & Shaul, P. W. (1999). Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. Journal of Clinical Investigation, 103(3), 401–406.CrossRefPubMed
50.
Lieberman, E. H., Gerhard, M. D., Uehata, A., Walsh, B. W., Selwyn, A. P., Ganz, P., et al. (1994). Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Annals of Internal Medicine, 121(12), 936–941.PubMed
51.
Kolodgie, F. D., Jacob, A., Wilson, P. S., Carlson, G. C., Farb, A., Verma, A., et al. (1996). Estradiol attenuates directed migration of vascular smooth muscle cells in vitro. American Journal of Pathology, 148(3), 969–976.PubMed
52.
Bailey, A. L., Scantlebury, D. C., & Smyth, S. S. (2009). Thrombosis and antithrombotic therapy in women. Arteriosclerosis, Thrombosis, and Vascular Biology, 29(3), 284–288. Epub 2009 Feb 16. Review.CrossRefPubMed
53.
Dechering, K., Boersma, C., & Mosselman, S. (2000). Estrogen receptors alpha and beta: two receptors of a kind? Current Medicinal Chemistry, 7(5), 561–576.PubMed
54.
Adams, M. R., Kaplan, J. R., Manuch, S. B., et al. (1990). Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Atherosclerosis, 10, 1051–1057.
55.
Wagner, J. D., Clarkson, T. B., Clair RW, S., Schwenke, D. C., Shively, C. A., & Adams, M. R. (1992). Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. Journal of Clinical Investigation, 88, 1995–2002.CrossRef
56.
Paoletti, R., Cosignani, P. G., Kenemans, P., et al. (1997). Menopause: problems and interventions in the United States. In R. Paoletti, P. G. Cosignani, P. Kenemans, G. Samsoe, M. Soma & A. S. Jackson (Eds.), Women’s health and menopause (pp. 9–14). Norwell: Kluwer.
57.
Sheifer, S. E., Canos, M. R., Weinfurt, K. P., Arora, U. K., Mendelsohn, F. O., Gersh, B. J., et al. (2000). Sex differences in coronary artery size assessed by intravascular ultrasound. American Heart Journal, 139(4), 649–653.CrossRefPubMed
58.
Herrington, D. M., Brown, W. V., Mosca, L., Davis, W., Eggleston, B., Hundley, W. G., et al. (2004). Relationship between arterial stiffness and subclinical aortic atherosclerosis. Circulation, 110(4), 432–437.CrossRefPubMed
59.
De Bruyne, B., Hersbach, F., Pijls, N. H., Bartunek, J., Bech, J. W., Heyndrickx, G. R., et al. (2001). Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "Normal" coronary angiography. Circulation, 104(20), 2401–2406.CrossRefPubMed
60.
Pepine, C. J., Kerensky, R. A., Lambert, C. R., Smith, K. M., von Mering, G. O., Sopko, G., et al. (2006). Some thoughts on the vasculopathy of women with ischemic heart disease. Journal of the American College of Cardiology, 47(3 Suppl), S30–S35.CrossRefPubMed
61.
Wong, T. Y., Klein, R., Sharrett, A. R., Duncan, B. B., Couper, D. J., Tielsch, J. M., et al. (2002). Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. JAMA, 287(9), 1153–1159.CrossRefPubMed
62.
von Mering, G. O., Arant, C. B., Wessel, T. R., McGorray, S. P., Bairey Merz, C. N., Sharaf, B. L., et al. (2004). Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation, 109(6), 722–725.CrossRef
63.
Wiviott, S. D., Cannon, C. P., Morrow, D. A., Murphy, S. A., Gibson, C. M., McCabe, C. H., et al. (2004). Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy. Circulation, 109(5), 580–586.CrossRefPubMed
Metadaten
Titel
Solutions for Disparities for Women with Heart Disease
verfasst von
Kathryn M. O’Callaghan
Publikationsdatum
01.12.2009
Verlag
Springer US
Erschienen in
Journal of Cardiovascular Translational Research / Ausgabe 4/2009
Print ISSN: 1937-5387
Elektronische ISSN: 1937-5395
DOI
https://doi.org/10.1007/s12265-009-9125-6

Weitere Artikel der Ausgabe 4/2009

Journal of Cardiovascular Translational Research 4/2009 Zur Ausgabe

EditorialNotes

Research.... Beyond Experiments!

OriginalPaper

Mechanical and Energetic Consequences of HCM-Causing Mutations

OriginalPaper

The Left Ventricular Outflow in Hypertrophic Cardiomyopathy: From Structure to Function

OriginalPaper

Response of Novel Biomarkers to BNP Infusion in Patients with Decompensated Heart Failure: A Multimarker Paradigm

OriginalPaper

Experimental Therapies in Hypertrophic Cardiomyopathy

OriginalPaper

Evolving Anatomic, Functional, and Molecular Imaging in the Early Detection and Prognosis of Hypertrophic Cardiomyopathy

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise